Below is an excerpt of an article co-authored by Government Enforcement and White-Collar Defense Team co-chair  Seth Orkand, published in G2 Intelligence on March 25, 2024 .

Recent enforcement actions have made clear that fraud, waste, and abuse is a continual concern of regulating agencies for the healthcare space, including for clinical laboratories. Reports by the U.S. Department of Health and Human and Services (HHS), the Office of Inspector General (OIG) and the U.S. Department of Justice (DOJ) in late 2023 highlighted their continued focus on clinical laboratories. Read the article.